BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 160613)

  • 1. Human T-lymphocyte subpopulations: alterations in systemic lupus erythematosus.
    Moretta A; Mingari MC; Santoli D; Perlmann P; Moretta L
    Scand J Immunol; 1979; 10(3):223-8. PubMed ID: 160613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
    Moutsopoulos HM; Fauci AS
    J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal T cell regulation of IgG synthesis in systemic lupus erythematosus.
    Nies KM; Stevens RH; Louie JS
    J Clin Lab Immunol; 1980 Sep; 4(2):69-75. PubMed ID: 6449594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic suppression of polyclonal immunoglobulin production in normals and patients with systemic lupus erythematosus.
    Clough JD; Krakauer RA; Frank SA; Calabrese LH
    Clin Exp Immunol; 1980 Oct; 42(1):27-32. PubMed ID: 6450653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defects of autologous mixed lymphocyte reaction-activated immunoregulatory T cells in patients with systemic lupus erythematosus.
    Koide J; Takeuchi T; Hosono O; Takano M; Abe T
    Scand J Immunol; 1987 Oct; 26(4):363-9. PubMed ID: 2961048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating and pokeweed mitogen-induced immunoglobulin-secreting cells in systemic lupus erythematosus.
    Ginsburg WW; Finkelman FD; Lipsky PE
    Clin Exp Immunol; 1979 Jan; 35(1):76-88. PubMed ID: 154983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of immune functions of patients with systemic lupus erythematosus. T-cell subsets and antibodies to T-cell subsets.
    Sakane T; Steinberg AD; Reeves JP; Green I
    J Clin Invest; 1979 Nov; 64(5):1260-9. PubMed ID: 159312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of anti-lymphocyte antibody of patients with active SLE. I. Cause of loss of suppressor T-lymphocyte function.
    Morimoto C; Abe T; Toguchi T; Kiyotaki M; Homma M
    Scand J Immunol; 1979; 10(3):213-21. PubMed ID: 160612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressor T cell dysfunction and depressed immunoglobulin production by B cells in vitro in patients with SLE.
    Nishinarita S; Takizawa I; Hirai H; Morita K; Amaki I
    J Rheumatol; 1981; 8(1):19-30. PubMed ID: 6452522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin production in vitro by peripheral blood lymphocytes in systemic lupus erythematosus: helper T cell defect and B cell hyperreactivity.
    Tan P; Pang G; Wilson JD
    Clin Exp Immunol; 1981 Jun; 44(3):548-54. PubMed ID: 6799237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired immunoregulation in systemic lupus erythematosus: defective adenosine-induced suppressor T lymphocyte generation.
    Kammer GM; Birch RE; Polmar SH
    J Immunol; 1983 Apr; 130(4):1706-12. PubMed ID: 6220065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired immunoglobulin M synthesis by peripheral blood lymphocytes in systemic lupus erythematosus: a primary B-cell defect.
    Nies KM; Stevens RH; Louie JS
    Clin Immunol Immunopathol; 1981 Apr; 19(1):118-30. PubMed ID: 6452238
    [No Abstract]   [Full Text] [Related]  

  • 13. Two distinct subsets of patients with systemic lupus erythematosus.
    McInerney MF; Clough JD; Senitzer D; Cathcart MK
    Clin Immunol Immunopathol; 1988 Oct; 49(1):116-32. PubMed ID: 2970355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct demonstration of immunoregulatory T-cell defects in patients with systemic lupus erythematosus.
    Koide J; Takano M; Takeuchi T; Hosono O; Amano K; Homma M; Abe T
    Scand J Immunol; 1986 Apr; 23(4):449-59. PubMed ID: 2939553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoregulatory T cell subpopulations in man: dissection by monoclonal antibodies and Fc-receptors.
    Ballieux RE; Heijnen CJ
    Immunol Rev; 1983; 74():5-28. PubMed ID: 6226587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced susceptibility to anti-Fab antibodies of B cells in patients with systemic lupus erythematosus.
    Suzuki H; Sakurami T; Imura H
    Int Arch Allergy Appl Immunol; 1982; 69(4):296-301. PubMed ID: 6982872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunction of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells.
    Sakane T; Steinberg AD; Green I
    Arthritis Rheum; 1978; 21(6):657-64. PubMed ID: 153749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro immune response of SLE lymphocytes. The mechanism involved in B-cell activation.
    Takeuchi T; Abe T; Kiyotaki M; Toguchi T; Koide J; Morimoto C; Homma M
    Scand J Immunol; 1982 Nov; 16(5):369-77. PubMed ID: 6758109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of suppressor activity on B-cell differentiation in human T-cell subset without fc(IgG) receptors by levamisole administration.
    Moriya N; Miyawaki T; Seki H; Kubo M; Nagaoki T; Okuda N; Taniguchi N
    Scand J Immunol; 1979; 10(6):535-41. PubMed ID: 161651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of immunoglobulin G from patients with systemic lupus erythematosus on human B cell function.
    Ramirez F; Searles RP; Williams RC
    Clin Immunol Immunopathol; 1987 Aug; 44(2):219-34. PubMed ID: 3111767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.